TY  - RPRT
TI  - OLFML2B promotes hepatocellular carcinoma malignancy via the PI3K/AKT-EMT axis and correlates with an immunosuppressive tumor microenvironment.
AU  - Xiaoling Liu
AU  - Yonghong Wang
AU  - Jingjing Bai
AU  - Cunliang Deng
AU  - Changfeng Sun
PY  - 2026
DO  - 10.3389/fimmu.2026.1779625
UR  - https://pubmed.ncbi.nlm.nih.gov/42683247/
ID  - 42683247
ER  -